Reply to correspondence on “Novel near-infrared probe for monitoring lipid peroxidation-mediated viscosity change in ferroptotic hepatocytes” Yunseo Bong, Wonhyo Seo Clinical and Molecular Hepatology.2026; 32(3): e437. CrossRef
Le Bich Hang Pham, Taeeung Kim, Seoyoung Kim, Yun Seok Kim, Jiyeon Kim, Kyeongseon Kim, Hyeonwoo Lim, Wan Seob Shim, Byoungmo Kim, So-Yeol Yoo, Jae-Young Lee, Murim Choi, Won Kim, Keon Wook Kang, Jeeyeon Lee
Clin Mol Hepatol 2026;32(1):318-338. Published online November 17, 2025
Background/Aims Ferroptosis, recently emerged as a new cell death modality characterized by iron-dependent peroxidation of lipids, has been explored in various diseases. However, detection of ferroptosis, particularly in chronic liver disease models, is hampered by the lack of universal ferroptosis markers and limited number of fluorescence sensors for in vivo ferroptosis.
Methods In this study, we developed TTM-4 as a highly sensitive near-infrared (NIR) fluorescent probe to detect ferroptosis.
Results TTM-4 exhibited turn-on fluorescence upon viscosity change, enabling visualization of lipid peroxidation (LPO) in ferroptotic hepatocytes and liver tissue samples with greater sensitivity than BODIPY 581/591 C11. Timelapse live-cell imaging of erastin-treated cells revealed real-time LPO dynamics involving cytosolic lipid droplets (cLDs), endoplasmic reticulum, and nuclear LDs in a chronological order. Further gene expression analysis of 216 liver tissue samples from the NCBI GEO database showed a significant increase in CIDEC concurrent with TTM-4 fluorescence during progression to metabolic dysfunction-associated steatotic hepatitis (MASH). TTM-4, with its low toxicity and turn-on NIR emission during ferroptosis, also enabled in vivo visualization of ferroptosis in liver injury and metabolic dysfunction-associated steatotic liver disease (MASLD) models.
Conclusions Our findings suggest that TTM-4 enables monitoring of ferroptosis in MASLD and would aid in early MASH diagnosis.
Citations
Citations to this article as recorded by
Targeting ferroptosis to halt MASLD and MASH Fudi Wang Trends in Endocrinology & Metabolism.2026; 37(8): 736. CrossRef
The Spatial Redox–Metalloptosis Axis in Liver Disease: A Hypothesis on Regional Susceptibility to Ferroptosis and Cuproptosis Zhaomin Dong, Maoshen Gong, Guangji Wang, Hong Wang Antioxidants.2026; 15(9): 1053. CrossRef
A water-soluble H2O2-activatable NIR fluorescence/photoacoustic probe with viscosity-modulated output for longitudinal imaging of drug-induced liver injury Xufeng Hou, Zhikang Wang, Jiahui Li, Cunxiao Li, Zhihong Xu, Quanli Lu, Jihong Huang, Tony D. James Sensors and Actuators B: Chemical.2026; 469: 140851. CrossRef
Amal Magdy, Hee-Jin Kim, Hanyong Go, Jun Min Lee, Hyun Ahm Sohn, Keeok Haam, Hyo-Jung Jung, Jong-Lyul Park, Taekyeong Yoo, Eun-Soo Kwon, Dong Hyeon Lee, Murim Choi, Keon Wook Kang, Won Kim, Mirang Kim, on behalf of the Innovative Target Exploration of NAFLD (ITEN) Consortium
Clin Mol Hepatol 2024;30(4):824-844. Published online July 25, 2024
Background/Aims Blocking the complement system is a promising strategy to impede the progression of metabolic dysfunction–associated steatotic liver disease (MASLD). However, the interplay between complement and MASLD remains to be elucidated. This comprehensive approach aimed to investigate the potential association between complement dysregulation and the histological severity of MASLD.
Methods Liver biopsy specimens were procured from a cohort comprising 106 Korean individuals, which included 31 controls, 17 with isolated steatosis, and 58 with metabolic dysfunction–associated steatohepatitis (MASH). Utilizing the Infinium Methylation EPIC array, thorough analysis of methylation alterations in 61 complement genes was conducted. The expression and methylation of nine complement genes in a murine MASH model were examined using quantitative RT-PCR and pyrosequencing.
Results Methylome and transcriptome analyses of liver biopsies revealed significant (P<0.05) hypermethylation and downregulation of C1R, C1S, C3, C6, C4BPA, and SERPING1, as well as hypomethylation (P<0.0005) and upregulation (P<0.05) of C5AR1, C7, and CD59, in association with the histological severity of MASLD. Furthermore, DNA methylation and the relative expression of nine complement genes in a MASH diet mouse model aligned with human data.
Conclusions Our research provides compelling evidence that epigenetic alterations in complement genes correlate with MASLD severity, offering valuable insights into the mechanisms driving MASLD progression, and suggests that inhibiting the function of certain complement proteins may be a promising strategy for managing MASLD.
Proteomics Insight into the Pathogenic Evolution of Chronic Hepatitis B across Distinct Clinical Stages Junhua Xie, Jun Lai, Yanzhe Zhang, Ye Liu, Zhixiang Yan Journal of Proteome Research.2026; 25(2): 936. CrossRef
Transcriptional and epigenetic regulation of Ca2+-signaling genes in hepatitis B-derived hepatocellular carcinoma and their association with the cancer hallmarks Guadalupe Hernández-Martínez, Andrés Hernández-Oliveras, Ángel Zarain-Herzberg, Juan Santiago-García, Kieran Campbell Bioinformatics Advances.2026;[Epub] CrossRef
Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance? Heechul Nam, Sung Won Lee Alimentary Pharmacology & Therapeutics.2026; 63(10): 1427. CrossRef
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease Nicola Pugliese, Trenton M. White, Paul N. Brennan, Silvana Pannain, Hannes Hagström, Maurice Michel, Lisa Rice-Duek, Giovanni Targher, Cyrielle Caussy, John F. Dillon, Frank Tacke, Christopher J. Kopka, Giada Sebastiani, Jerome Boursier, Emmanuel A. Tsoc The Lancet Regional Health - Europe.2026; 65: 101722. CrossRef
Integrative multi-omics analysis identifies stellate cell-derived complement component 7 as a predictor of fibrosis and liver-related events in MASLD Shohei Kondo, Takefumi Kimura, Takanobu Iwadare, Mohammad Taufeeq, Takao Miwa, Naoyuki Fujimori, Tomoyuki Nakajima, Shun-ichi Wakabayashi, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Satsuki Isogai, Tomoo Yamazaki, Mai Iwaya, Takeshi Uehara, Takeji JHEP Reports.2026; 8(11): 101965. CrossRef
Gut microbiota and the gut–liver axis in MASLD: mechanisms, immune regulation and therapeutic opportunities Jingjing Liu, Mei Zhao, Shujing Wang, Chengyong Zhang, Yingli Zhong, Yuanjun Qu Frontiers in Pharmacology.2026;[Epub] CrossRef
Targeting the Complement C1 Proteases Using Camelid-Derived Single Domain Antibodies: Production, Characterization and Possible Application for Tissue/Fluid Analysis Nolwenn Haut, Véronique Rossi, Julie Peliconi, Jean-Baptiste Reiser, Nicole M. Thielens, Lubka T. Roumenina, Christine Gaboriaud Antibodies.2026; 15(5): 92. CrossRef
Calpain-1 Deficiency Alleviates Oxidative Stress and Hepatic Injury in ApoE-deficient Mice with MASH Wenjiao Gu, Yujie Wei, Shuangyi Li, MOHAMED ALI AWAD, Youming Shi, Ying Jiang, Xiaochun Zhou, Zhimin Wang, Jixin Liu, Futian Tang Tissue and Cell.2026; : 104024. CrossRef
Exposure-shaped immunometabolic networks in chronic liver disease: translating multi-omics and artificial intelligence into preventive biomarkers Hailin Wang, Qinqin Tang, Juan Hu, Jingdong Li, Qiushi Huang Frontiers in Immunology.2026;[Epub] CrossRef
Abnormal lipid metabolism in metabolic dysfunction-associated steatohepatitis (MASH) Wonseok Lee, You-Jin Choi, Hyuneui Park, Suwan Chae, Byung-Hoon Lee Toxicological Research.2026;[Epub] CrossRef
Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver disease Jun-Jie Wang, Xiao-Yuan Chen, Yi-Rong Zhang, Yan Shen, Meng-Lin Zhu, Jun Zhang, Jun-Jie Zhang Frontiers in Physiology.2025;[Epub] CrossRef
Uncovering hepatic transcriptomic and circulating proteomic signatures in MASH: A meta-analysis and machine learning-based biomarker discovery Elena Cristina Rusu, Helena Clavero-Mestres, Mario Sánchez-Álvarez, Marina Veciana-Molins, Laia Bertran, Pablo Monfort-Lanzas, Carmen Aguilar, Javier Camaron, Teresa Auguet Computers in Biology and Medicine.2025; 191: 110170. CrossRef
Sepsis-related immune signature C3 in endometrial carcinoma: implications for prognosis, tumor progression through bioinformatics and experimental validation Kulsoom, Wajahat Ali, Saleem Ahmad, Irfan Ali Khan, Tanveen Kaur Soni, Asia Masood, Muhammad Omer Iqbal, Valisher Sapayev Odilbek uglu, Mukhayya Xusinovna Djumaniyazova, Anas Sameed Cholavaram, Mubaraq Arisekola Abdulrahmon Molecular Biology Reports.2025;[Epub] CrossRef
Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration Evelien Van Dijck, Steven Van Laere, Emilie Logie, Steven Timmermans, Erik Fransen, Joe Ibrahim, Timothy J. Kendall, Jonathan A. Fallowfield, Ligia M. Mateiu, Claude Libert, Guy Van Camp, An Verrijken, Luc Van Gaal, Sven Francque, Wim Van Hul, Wim Vanden Clinical Epigenetics.2025;[Epub] CrossRef
Recent progress in histone post-translational modifications as regulators of metabolic diseases: A review Aiqiang Zhu, Tong Ye, Minjia Tan, Jun-Yu Xu International Journal of Biological Macromolecules.2025; 330: 147964. CrossRef
First
Prev
